I agree that this site is using cookies. You can find further informations here.
X
Trojanec, R.
18  results:
Search for persons X
?
1

P14.68 Life expectancy in biopsied GBM patients: a single-c..:

Kalita, O ; Sporikova, Z ; Halaj, M...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii83-iii83 , 2019
Link: https://doi.org/10.1093/..
 
?
2

P01.038Drug resistance and recurrence in glioblastoma: mole..:

Šporiková, Z ; Megová Houdová, M ; Trojanec, R...
Neuro-Oncology.  20 (2018)  suppl_3 - p. iii237-iii237 , 2018
Link: https://doi.org/10.1093/..
 
?
3

P01.098Have we been still defeated with treatment of GBM ID..:

Kalita, O ; Vaverka, M ; Hrabalek, L...
Neuro-Oncology.  20 (2018)  suppl_3 - p. iii253-iii253 , 2018
Link: https://doi.org/10.1093/..
 
?
4

P06.09 Genetic alterations in patients with resection of pr..:

Trojanec, R. ; Kalita, O. ; Megova, M....
Neuro-Oncology.  18 (2016)  suppl_4 - p. iv29-iv29 , 2016
Link: https://doi.org/10.1093/..
 
?
5

P08.70 Prognostic and predictive factors in primary Gliobla..:

Kalita, O. ; Hajduch, M. ; Trojanec, R....
Neuro-Oncology.  18 (2016)  suppl_4 - p. iv58-iv58 , 2016
Link: https://doi.org/10.1093/..
 
?
6

P06.10 A retrospective single-center study of IDH mutations..:

Megova, M. ; Drabek, J. ; Trojanec, R....
Neuro-Oncology.  18 (2016)  suppl_4 - p. iv29-iv30 , 2016
Link: https://doi.org/10.1093/..
 
?
7

Glioblastoma multiforme in patients with history of extracr..:

Kalita, O. ; Trojanec, R. ; Megova, M....
Clinical Neurology and Neurosurgery.  144 (2016)  - p. 39-43 , 2016
Link: https://doi.org/10.1016/..
 
?
8

265 BCL11A gene status and prediction of survival in triple..:

Bouchalova, K. ; Svoboda, M. ; Kharaishvili, G....
European Journal of Cancer.  51 (2015)  - p. S48 , 2015
Link: https://doi.org/10.1016/..
 
?
9

P17.44 * THE EFFECT OF A SURGERY RATIONALE ON LIFE EXPECTAN..:

Kalita, O. ; Vaverka, M. ; Hrabalek, L....
Neuro-Oncology.  16 (2014)  suppl 2 - p. ii97-ii97 , 2014
Link: https://doi.org/10.1093/..
 
?
10

582 ALK Rearrangement and EGFR Copy Number Gains/mutations ..:

Koudelakova, V. ; Trojanec, R. ; Kneblova, M....
European Journal of Cancer.  48 (2012)  - p. S139 , 2012
Link: https://doi.org/10.1016/..
 
?
11

Role of CCND1 and C-MYC oncogenes in metastatic breast canc..:

Trojanec, R ; Koudelakova, V ; Bouchalova, K...
Breast Cancer Research.  13 (2011)  S2 - p. , 2011
Link: https://doi.org/10.1186/..
 
?
12

BCL2 is a predictive marker of adjuvant CMF regimen in trip..:

Bouchalova, K ; Cizkova, M ; Trojanec, R...
Breast Cancer Research.  13 (2011)  S2 - p. , 2011
Link: https://doi.org/10.1186/..
 
?
13

The status and role of ErbB receptors in human cancer:

Überall, I. ; Kolář, Z. ; Trojanec, R...
Experimental and Molecular Pathology.  84 (2008)  2 - p. 79-89 , 2008
Link: https://doi.org/10.1016/..
 
?
14

P17.44THE EFFECT OF A SURGERY RATIONALE ON LIFE EXPECTANCY ..:

Kalita, O ; Vaverka, M ; Hrabalek, L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185742/.  , 2014
Link: http://www.ncbi.nlm.nih...
 
?
15

BCL2 is a predictive marker of adjuvant CMF regimen in trip..:

Bouchalova, K ; Cizkova, M ; Trojanec, R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247056.  , 2011
Link: http://www.ncbi.nlm.nih...
 
1-15